MSFT
53
-2
CPB
22
-2
KR
46
-4
C
51
3
QCOM
56
6
AA
31
4
PCG
61
2
R
59
4
XRAY
31
2
PM
47
-2
PAYX
39
3
HP
34
-10
PSA
45
2
HSIC
44
2
PGR
49
4
IBM
51
-2
NRG
37
5
AAL
54
-2
MAC
51
-2
WFC
60
2
MSFT
53
-2
CPB
22
-2
KR
46
-4
C
51
3
QCOM
56
6
AA
31
4
PCG
61
2
R
59
4
XRAY
31
2
PM
47
-2
PAYX
39
3
HP
34
-10
PSA
45
2
HSIC
44
2
PGR
49
4
IBM
51
-2
NRG
37
5
AAL
54
-2
MAC
51
-2
WFC
60
2
Financhill
Back

Daiichi Sankyo 10K Form

Sell
21

DSNKY
Daiichi Sankyo

Last Price:
$27.85
Seasonality Move:
6.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DSNKY News And Ratings

See the #1 stock for the next 7 days that we like better than DSNKY

DSNKY Financial Statistics

Sales & Book Value

Annual Sales: $11.1B
Cash Flow: $-43M
Price / Cash Flow: 17.54
Annual Sales: $5.82
Price / Book: 4.65

Profitability

EPS (TTM): 0.79560
Net Income (TTM): $1.5B
Gross Margin: $8.2B
Return on Equity: 12.79%
Return on Assets: 7.46%

Daiichi Sankyo Earnings Forecast

Key Daiichi Sankyo Financial Ratios

  • The Gross Profit Margin over the past 25 years for DSNKY is 74.07%.
  • The Selling, General & Administrative Expenses for DSNKY have been equal to 39.77% of Gross Profit Margin.
  • The Research & Development expenses have been 22.80% of Revenue.
  • The Interest Expense is 3.00% of Operating Income.
  • The Net Earning history of DSNKY is 12.53% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 14 years.

Daiichi Sankyo Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: DSNKY
Website: daiichisankyo.com

Debt

Debt-to-Equity Ratio: 0.06
Current Ratio: 3.01
Quick Ratio: 2.32

Price-to-Earnings

Trailing P/E Ratio: 38.52
Forward P/E Ratio: 0

DSNKY Technical Analysis vs Fundamental Analysis

Sell
21
Daiichi Sankyo (DSNKY) is a Sell

Is Daiichi Sankyo a Buy or a Sell?

  • Daiichi Sankyo stock is rated a Sell
    The current Daiichi Sankyo [DSNKY] share price is $27.93. The Score for DSNKY is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.